Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 83

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 83
---
 Resolution. Indemnification/Insurance The Company’s by-lawsprovide for indemnification of directors and officers against certain liabilities that may arise by reason of their status or service as directors or officers. In addition, pursuant to the Agreement, the Purchaser will, or will cause the Company to, purchase customary fully pre-paidand non-cancelable“tail” policies of directors’ and officers’ liability, fiduciary liability, and employment practices liability providing protection no less favorable in the aggregate than the protection provided by such policies maintained by or for the benefit of the Company which are in effect immediately prior to the Effective Time, and the Purchaser shall, or shall cause the Company to maintain such tail policies in full force and effect without any reduction in scope of coverage or limits (other than a reduction of limits due to payments by the insurer(s) under the policies) for six (6) years after the Effective Date. Compensation of the Transaction Committee The Transaction Committee consists of four independent members of the Board: David Bonita (Chair), Thomas Civik, Samarth Kulkarni and Carol A. Schafer. Members of the Transaction Committee did not receive any additional remuneration for their service on the Transaction Committee. Fees and Expenses Whether or not the Arrangement is consummated, all fees and expenses incurred in connection with the Arrangement will be paid by the Party incurring those fees and expenses, except that the Company will pay the costs of printing and mailing this Circular and Proxy Statement and all SEC filing fees with respect to the Arrangement. Additionally, if the Agreement is terminated under certain circumstances, the Company must pay the Termination Payment to the Purchaser. Total fees and expenses incurred or to be incurred by the Company in connection with the Arrangement are estimated at this time to be as follows:

|                                                                                                |     | Estimated    
 Amount To Be 
 Paid         
 (in millions 
 US$)         |     |
|:-----------------------------------------------------------------------------------------------|:----|:-------------|----:|
| Legal, accounting and other professional fees                                                  |     | $            | 3.4 |
| Financial advisory fee and expenses                                                            |     | $            | 4.0 |
| D&O clinical trial and other runoff insurance policies                                         |     | $            | 2.0 |
| SEC registration fee, printing and mailing costs, transfer agent fees and other administrative 
 costs                                                                                          |     | $            | 0.2 |
| Total                                                                                          |     | $            | 9.6 |

48